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Abstract 
A phytochemical and biological investigation of the endemic Mascarene Aloes (Aloe spp.), 
including A. tormentorii (Marais) L.E.Newton & G.D.Rowley, A. purpurea Lam, A. macra 
Haw., A. lomatophylloides Balf.f and A. vera (synonym A. barbadensis Mill.), which are used 
in the traditional folk medicine of the Mascarene Islands, was initiated. Methanolic extracts of 
the Aloes under study were analysed using high resolution LC-UV-MS/MS and compounds 
belonging to the class of anthraquinones, anthrones, chromones and flavone C-glycosides were 
detected. The Mascarene Aloes could be distinguished from A. vera by the absence of 2ʹʹ-O-
feruloylaloesin and 7-O-methylaloeresin. GC-MS analysis of monosaccharides revealed the 
presence of arabinose, fucose, xylose, mannose and galactose in all the Mascarene Aloes and 
in A. vera. The crude extracts of all Aloes analysed displayed antimicrobial activity against 
Bacillus cereus, Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa. Only 
extracts of A. macra were active against P. aeruginosa and Klebsiella pneumoniae, while none 
of the Aloe extracts inhibited Propionibacterium acnes. A. macra displayed anti-tyrosinase 
activity, exhibiting 50% inhibition at 0.95 mg/ml, and extracts of A. purpurea (Mauritius) and 
A. vera displayed activity in a wound healing-scratch assay. In vitro cytotoxicity screening of 
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crude methanolic extracts of the Aloes, using the MTT (3-(4, 5-dimethylthiazolyl-2)-2, 5-
diphenyltetrazolium bromide) showed that only A. purpurea (Réunion) elicited a modest toxic 
effect against HL60 cells, with a percentage toxicity of 8.2% (A. purpurea -Réunion) and none 
of the Aloe extracts elicited a toxic effect against MRC 5 fibroblast cells at a concentration of 
0.1 mg/ml. Mascarene Aloe species possess noteworthy pharmacological attributes  associated 
with their rich phytochemical profiles.  
 
Keywords: Mascarene Aloes biological activity, LC MS, GC MS, monosaccharides   
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1. Introduction 
The genus Aloe (Xanthorrhoeaceae) has been traditionally used in the medicinal practice for 
thousands of years in many cultures of the world. Today,  Aloe vera (L.) Burm.f. in particular 
has become a popular household remedy, reputed to exhibit a range of beneficial health 
properties. Some of the most widely known Aloe species adopted for their medicinal properties 
include A. vera (synonym A. barbadensis Mill.), A. ferox Mill. (vernacular name: Cape Aloe), 
A. arborescens Mill. (vernacular name: Candelabra Aloe), A. perryi Baker (vernacular name: 
Perry's Aloe), A. succotrina Weston and A. maculata All. A. vera is the most widely studied 
species, and has been evaluated for clinical efficacy against various diseases (Jia et al., 2008; 
Chinchilla et al., 2013). Leaves from Aloe species yield two known medicinal products: a gel 
obtained from parenchymal tissue of the leaf, and a bitter exudate known as 'bitter aloes' or 
'drug aloes', derived from pericycle cells beneath the epidermis. The bitter leaf exudate has 
been used worldwide as a laxative. Indeed, a monograph for the concentrated dried leaf juice 
of ‘Cape Aloe’ is included in the current European and British Pharmacopoeias (British 
Pharmacopoeia Commission, 2017). Whilst the leaves from many other Aloes have been 
documented as traditional medicinal remedies (Grace et al., 2008), there is a comparative lack 
of scientific evidence that documents the chemistry and biological activities of the less widely 
known Aloe species, to validate their reputed medicinal effects. 
  
The Mascarene Islands, which comprise Mauritius, Rodrigues and Réunion, have a rich and 
diverse flora and many indigenous and endemic plant species of these Islands have been used 
in folk medicine to treat various illnesses. However, even with this well-documented traditional 
knowledge, few medicinal plant species, including Mascarene Aloe species, have been 
scientifically validated for their medicinal uses. The Mascarene Aloes which belong to the 
former Aloe section lomatophyllum include Aloe tormentorii and A. purpurea, commonly 
known as ‘Mazambron marron’, are species endemic to Mauritius (Bosser et al., 1976; Gurib-
Fakim, 2003); Aloe macra (Bosser et al., 1976; Pailler et al., 2000) is endemic to Réunion 
Island and A. lomatophylloides (Govinden-Soulange, 2014) is native to Rodrigues Island. The 
Mascarene Aloes are documented to have a range of medicinal properties. In Rodrigues, the 
crushed leaves of A. lomatophylloides Balf.f. have been applied as a poultice to relieve muscle 
pain, whilst a decoction of the leaves is taken to increase menstrual flow (Gurib-Fakim, 2003). 
The leaves of A. macra Haw. are used to alleviate minor infections, boils, constipation and as 
a general healing substance for external use (Govinden-Soulange, 2014), whilst the leaf sap of 
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A. purpurea Lam. is applied to the breast to encourage weaning. The Mascarene Aloes are also 
used internally as antispasmodics and to relieve discomfort associated with menstruation 
(Gurib-Fakim., 2003). It is widely known that the hydroxyanthracene glycoside derivatives that 
occur in Aloe spp. explain their use as laxatives, while the polysaccharide gel of A. vera has 
been associated with the biological activities relevant to skin disorders and cosmetic use 
(Chinchilla et al., 2013).  
 
The chemical constituents and biological activities that might explain the traditional and 
potential uses of the Mascarene Aloes, particularly any mechanisms relevant to dermatological 
uses, are largely unexplored to date. Previous studies investigated the morphological 
characteristics of A. macra, A, tormentorii (Marais) L.E.Newton & G.D.Rowley, A. purpurea, 
and the genetic differences between these Aloe species and A. vera, were compared, and 
flavone glycosides were identified (Ranghoo-Sanmukhiya et al., 2010). The uniqueness of 
Mascarene Aloes as compared to A. vera was confirmed using phylogenetic analysis of 
sequence data and the superior antioxidant activity and neuroprotective property of these 
species has been previously reported (Govinden-Soulange et al., 2017; Lobine et al., 2017). In 
the present report, further studies have been initiated to validate their traditional use and to 
evaluate their potential as sustainable phytomedicines. Five different endemic Mascarene Aloe 
species were investigated using different approaches, with direct comparison of their biological 
activities with A. vera.  
 
2. Materials and Methods  
2.1. Plant material collection  
Leaves from five-year old plants of A. purpurea Lam., A. tormentorii (Marais) L.E.Newton & 
G.D.Rowley, A. lomatophyllloides Balf.f., A. macra Haw. and A. vera (L.) Burm.f. were 
obtained from the National Parks and Conservation Service (Mauritius) and Mauritius 
Herbarium garden, MSIRI and Conservatoire Botanique National de Mascarin (Réunion 
Island). A voucher specimen of each Mascarene Aloe species: A. purpurea (Mauritius) [MAU 
0014447]; A. tormentorii [MAU 0014094]; A. lomatophylloides [MAU 0014095]; A. macra 
[WV 99110 and WS990130]; A. purpurea (Réunion Island) [WS 99067], was deposited at the 
Herbarium of the Mauritius Sugar Industry Research Institute (Réduit, Mauritius). The leaves 
were lyophilised and stored in air-tight bottles. A. purpurea from Réunion has been reported as 
a putative hybrid of A. macra and A. tormentorii (Ranghoo-Sanmukhiya et al., 2010). A. macra 
[WV 990110] and A. macra [WS990130] are morphologically different from each other, and 
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are thus suspected to be two different varieties. The leaves of A. macra [WV 990110] are green, 
while A. macra [WS990130] has prominent red-toned leaves, with both growing in the same 
habitat. A potential new Aloe species [WS 98002], which is undergoing evaluation to determine 
its taxonomic status, is also reported. We emphasize that with respect to species conservation 
strategies, only limited quantities of the Aloe spp. [WS 98002] and A. macra ('forme rouge') 
[WS 98 0130] were collected but were not subjected to bioassay studies, although their 
chemistry was evaluated using gas chromatography-mass spectrometry (GC-MS) and high 
resolution liquid chromatography-mass spectrometry coupled with UV detection (LC-UV-
MS/MS).  
 
2.2. LC-UV-MS/MS analysis  
Analyses were performed on a Thermo Scientific system consisting of an ‘Accela’ U-HPLC 
unit with a photodiode array detector and an ‘LTQ Orbitrap XL’ mass spectrometer fitted with 
an electrospray source (Thermo Scientific, Waltham, MA, USA). Chromatography was 
performed on 5 µL samples (70% methanol extracts; as described in 2.4.) injected onto a 150 
mm x 3 mm, 3 µm Luna C-18 column (Phenomenex, Torrance, CA, USA) using the following 
400 µL/min mobile phase gradient of H2O/CH3OH/CH3CN +1% HCOOH: 90:0:10 (0 min), 
90:0:10 (5 min), 0:90:10 (60 min), 0:90:10 (65 min), 90:0:10 (67 min), 90:0:10 (70 min) 
followed by a return to start conditions and equilibration in start conditions for 5 min before 
the next injection. The electrospray ionization (ESI) source was operated with polarity 
switching and the mass spectrometer was set to record high resolution (30 k resolution) MS1 
spectra (m/z 125–2000) in positive mode using the orbitrap and low resolution MS1 spectra 
(m/z 125– 2000) in negative mode and data dependent MS2 and MS3 spectra in both modes 
using the linear ion trap. Detected compounds were assigned by comparison with accurate mass 
data (based on ppm), and by available MS/MS data, with reference to the published compound 
assignment system (Schymanski et al., 2014) and supportive UV spectra; aloin A was also 
assigned by comparison with a reference standard (≥97%; Sigma-Aldrich, UK). 
 
2.3. Determination of monosaccharide composition using GC-MS 
Lyophilised mesophyll tissue (10 mg) of each Mascarene Aloe species was re-suspended in 
500 µL of sterile distilled water and allowed to rehydrate in a sonicating water bath for 1 h. 
The material was acidified to 2 M trifluoroacetic acid (TFA) and 100 µg internal standard 
(inositol) was added, followed by incubation at 110 °C for 2 h in sealed glass sample tubes, 
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prior to centrifugation at 14,000 xg for 30 min and the supernatants were dried under nitrogen 
at 40°C. 400 µL of methanolic 1N HCl was added to the dried residue and incubated at 80°C 
overnight then dried under nitrogen at 40°C after addition of 100 µL tert-butanol. 1-
(Trimethylsilyl) imidazole-pyridine (400 µL) was added to each sample, which were then 
incubated at 80°C for 30 min, dried under nitrogen at 40°C prior to re-suspension in 1 mL 
hexane for GC-MS analysis. 
 
The GC-MS analyses were performed using a single-quadrupole Shimadzu QP-2010-Plus 
system fitted with a Restek Rxi-5Sil column (30 m × 0.25 mm × 0.25 µm). 2 µL of samples 
were introduced by split injection at a ratio of 1:20 and the carrier gas (helium) was set to a 
flow rate of 40 cm/sec. The injector temperature was 250 ⁰C and the initial oven temperature 
was 140 ⁰C, increasing at 2 ⁰C/minute to 180 ⁰C and held at this temperature for 5 minutes 
before increasing to 275 ⁰C at 10 ⁰C/minute, held for 10 minutes. The scan range was m/z 45 - 
1000. Seven monosaccharides (arabinose, fucose, galactose, glucose, mannose, xylose and 
inositol obtained from Supelco and Sigma-Aldrich) were used as reference standards, based on 
a previous study (Grace et al., 2011).  
 
2.4. Preparation of extracts for bioassays 
Lyophilised leaf samples (100 mg) of each Mascarene Aloe species were extracted in 10 mL 
of cold 70% (v/v) methanol, heated under reflux for 1 h, sonicated for 15 min and centrifuged 
for 10 min at 5000 rpm. The supernatant was filtered (0.45 µm filter) and analysed. For 
bioassays, the extracts were concentrated to dryness and the residues were re-suspended in 
water and stored in aliquots at -20°C. For all the experiments, dilutions of extracts were 
performed fresh on the day of the bioassay. 
 
2.5. Antimicrobial assay 
The serial dilution technique described by Eloff (1998) was used to determine the minimum 
inhibitory concentration (MIC) for antibacterial activity of the Aloe extracts. 2 mL cultures of 
five bacterial strains [two Gram-positive, Staphylococcus aureus (ATCC No. 12600) and 
Bacillus cereus (ATCC No: 11778); and three Gram-negative, Escherichia coli (ATCC No. 
11775), Pseudomonas aeruginosa (ATCC No: 27853) and Klebsiella pneumoniae (ATCC No. 
13883)] were prepared and incubated overnight at 37 °C. The overnight cultures were diluted 
with sterile MH (Mueller-Hinton) broth (1 mL bacteria/100 mL MH) to an absorbance of 0.4–
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0.6 at 600 nm. For each bacterial strain used, 100 µL of the Aloe extracts (50mg/mL) was 
serially diluted two-fold with 100 µL sterile distilled water in a sterile 96-well microplate. A 
similar two-fold serial dilution of streptomycin (Sigma-Aldrich; 0.01 mg/mL) was used as a 
positive control against each bacterium. Sterile distilled water was used as a negative control 
and 100 µL of bacterial culture was added to each well. The plates were covered, sealed and 
incubated overnight at 37 °C. Bacterial growth was determined by addition of 50 µL of 0.2 
mg/mL p-iodonitrotetrazolium violet (INT) to each well after incubation at 37 °C for 30 min. 
Bacterial growth in the wells was indicated by a red colour, and colourless wells indicated 
inhibition by the tested extracts. 
 
2.6. Anti-acne bioassay  
The Aloe extracts were tested against Propionibacterium acnes (ATCC 11827) by determining 
the MIC values obtained by a microdilution method as described by Sharma et al., (2014) with 
slight modifications. P. acnes (ATCC 11827) was cultured from a Kwik-Stick on mouse brain 
and heart agar and incubated under anaerobic conditions at 37°C for 72 h. The 72 h culture was 
suspended in nutrient broth and adjusted to an absorbance (A600nm) of 0.132. In a sterile 96-
well plate, 100 µL of the plant extracts [8 mg/mL in 10% dimethyl sulphoxide, (DMSO)] and 
the positive control tetracycline was diluted with nutrient broth (100 µL). Two-fold serial 
dilutions were made in the nutrient broth and the bacterial suspension (100 µL) was added to 
all the wells of the microtiter plate.  The final concentrations ranged from 2000-15.6 µg/mL 
for the plant extracts and 100-0.78 µg/mL for the positive control, tetracycline. To the control 
wells, 2.5% DMSO and bacterial suspension without additions served as the negative and 
bacterial controls, respectively. The plates were incubated for 72 h at 37 °C under anaerobic 
conditions. The MIC was determined by observation after addition of PrestoBlue reagent (20 
µL). 
 
2.7. Tyrosinase enzyme inhibition assay  
The Aloe extracts were dissolved in dimethyl sulfoxide (DMSO) to a final stock concentration 
of 20 mg/mL. The stock sample solutions were two-fold serially diluted in 50 mM potassium 
phosphate buffer (pH 6.5) to a starting concentration of 3 mg/mL. In a 96-well plate, the sample 
solutions (70 µL) were combined with 30 µL of tyrosinase (48 Units/mL) in triplicate. The 
plate was incubated for 5 minutes at room temperature before the addition of 2 mM L-tyrosine 
(110µL) to each well. The final concentration of the extracts ranged between 1000-7.8 µg/mL. 
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Kojic acid served as positive control with a final concentration ranging between 400-3.1 
µg/mL. The absorbance of the wells was analysed at 492 nm for 30 minutes at room 
temperature with a BIO-TEK PowerWave XS multi-well plate reader. The 50% inhibitory 
concentration (IC50) value was determined by using Graph Pad Prism 4 software (Momtaz et 
al., 2008).  
 
2.8. Wound healing (scratch) assay 
The spreading and migration capabilities of the human keratinocyte HaCaT cell line were 
assessed using a scratch wound assay, which measured the expansion of a cell population on 
surfaces. HaCaT cells were seeded into 24-well tissue culture plates for 24 h, at a concentration 
of 2 x 104 cells/mL, cultured in modified Eagle’s medium (DMEM) with 10% fetal bovine 
serum (FBS) and incubated for 24 h at 37 ºC with 5% CO2, to almost confluent cell monolayers. 
A linear wound was then generated in the monolayer with a sterile 100 μl plastic pipette tip. 
Any cellular debris was removed by washing the well gently with  phosphate buffer saline 
(PBS) (136.9 mM 2.68 mM KCl, 4.3 mM Na2HPO4, 1.4 mM KH2PO4, pH 7.4) and fresh 
DMEM medium was added and replaced with 2 mL of DMEM containing the Aloe extracts 
(0.1 mg/mL); DMEM without sample served as a control. Cell migration was monitored by 
collecting digitised images using a Leica SP5 confocal microscope at 5 min intervals for 20 h. 
The microscope stage was heated to 37 °C and the cells were incubated at 5% CO2 through the 
experiment. The data were analysed using Tscratch software (Gebäck et al., 2009). The 
percentage closed area was measured and compared with the value obtained before treatment. 
An increase in the percentage of the closed area indicated cell migration. The experiments were 
performed in replicates (n=6). 
 
2.9. Human promyelocytic leukaemia cell assay  
The Human promyelocytic leukaemia cells (HL60; kindly provided by Dr Nicholas Hole, 
Durham University) were cultured at 37°C in 5% CO2 on 75 cm
2 tissue culture flasks (Sarstedt, 
Newton, NC) in Dulbecco's modified Eagles' medium DMEM⁄F-12 Media - GlutaMAX™-I 
(GIBCO, Grand Island, NY), supplemented with 10% foetal bovine serum (FBS; Sigma, St. 
Louis, MO, USA). Cells were passaged every 3-4 days at a 1:4 dilution. For the assay, cell 
pellets were re-suspended in fresh medium at a concentration of 0.30 × 106 cells per mL and 
immediately plated in 24-well plates and incubated at 37°C with 5% CO2. Cells were exposed 
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to 0.1 mg/mL of the Aloe extracts with appropriate controls for 24 h before the cytotoxicity 
assay was performed (Pilarski et al., 2007). 
 
2.10. MRC 5 fibroblast assay 
The MRC 5 fibroblasts (ATCC CCL-171) were cultured via serial passage at 37oC in a 
humidified 5% CO2 atmosphere in Dulbecco’s Modified Eagle’s Medium (Gibco, Paisley, UK) 
supplemented with 1% (v/v) penicillin-streptomycin and 10% foetal bovine serum (LabTech). 
Once cultures reached 90% confluence, they were washed twice in warm PBS prior to 
incubation in trypsin for 5 min at 37 oC. When passaging into flasks, a 1:2 split ratio was 
maintained consistently. Cells were diluted in fresh medium and seeded into 24-well plates at 
a density of 2 x 104 per well. After incubation for 24 h, the cells were exposed to the Aloe 
extracts (0.1 mg/mL) and controls for 24 h before the cytotoxicity assay was performed. 
 
2.11. MTT cell viability assay 
The tetrazolium dye MTT (Sigma, UK) was used to assess the viability of HL60 and MRC 5 
fibroblasts after 24 h pre-treatment with Aloe extracts as described by Abuhamdah et al., 
(2015). 50 µL of PBS containing a final concentration of 5 mg/mL MTT was added to the 
cultures treated with the Aloe extracts (0.1 mg/mL) for 24 h and incubated at 37°C in 5% CO2 
for 2.5 h. The MTT-containing medium was then removed and the well surfaces were rinsed 
gently with 300 µL PBS prior to addition of 250 µL isopropanol. The absorbance of 100 µL 
samples was measured spectrophotometrically at 595 nm (Thermo Labsystems Multiskan 
Ascent, V1.3). 
 
2.12. Statistical Analysis  
All the experiments were performed in replicates (n = 3-6) and statistical analysis was carried 
out using one-way ANOVA followed by Tukey’s test, performed using SPSS 16.0. The values 
of p < 0.05 were considered to be statistically significant. 
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3. Results and Discussion 
 
3.1. LC-UV-MS/MS analysis 
The LC-MS chromatograms (positive ESI) for each Aloe extract, with the main detected 
compounds and their assignments, are shown in Figure 1. Hydroxycinnamic acids occurring as 
esters of quinic acid conjugated with caffeic (C16H18O9; 1) or coumaric acids were detected in 
all the investigated Aloes, except for A. tormentorii, in which only 4-O-p-coumaroylquinic acid 
(C16H18O8; 3) was detected, suggesting that this compound may be  useful to differentiate A. 
tormentorii from other Mascarene Aloes. A compound with m/z 395.1328 (C19H22O9; 2) was 
assigned as aloesin (formerly known as aloeresin B), and was detected in all the Aloe species 
investigated except in A. lomatophylloides. This suggests that a lack of aloesin may be useful 
to distinguish A. lomatophylloides from the other Mascarene Aloes. The thin leaves of A. 
lomatophylloides contain less exudate compared to other investigated Aloes, which may 
account for the absence of aloesin, which is a significant constituent of exudates of other Aloe 
species (Dagne et al., 2000; Cock, 2015). 
 
A compound (C28H28O11; 17) with m/z 541.1705 corresponded to aloeresin A or isomer. 
Compounds assigned from the observed [M+H]+ ions as C29H30O12 [the molecular formula of 
2"-O-feuloylaloesin (12)], and as C29H30O11 [the molecular formula of 7-O-methylaloeresin A 
(14) were only detected in the A. vera extract (m/z 571.1812 and 555.1873, respectively). 2"-
O-Feuloylaloesin and 7-O-methylaloeresin A were not detected in any of the Mascarene Aloes, 
so these might be useful marker compounds to distinguish these species from A. vera. 7-O-
Methylaloeresin A was first reported in Aloe marlothii A. Berger (Bisrat et al., 2000) and to 
our knowledge, has not been previously reported in any species from the former section 
Lomatophyllum. The phenyl pyrones have a restricted distribution in the genus Aloe, with 
aloenin occurring in only 16 out of the 380 Aloe species (Viljoen and Van Wyk, 2000). In this 
study, a compound (13) assigned as 2ʹʹ-O-trans-p-coumaroylaloenin (C28H28O12 or isomer; m/z 
557.1657) was detected in all the Mascarene Aloes except in A. lomatophylloides and A. vera.  
 
Previously, flavonoids were detected in only 31 of 380 Aloe species as major compounds, with 
the flavone isovitexin (apigenin 6-C-glucoside) considered as a chemotaxonomic marker 
restricted to the grass-like Aloes (Graminialoe and Leptopaloe), the Macrifolia and the 
Lomatophyllum section (Viljoen et al., 1998). In this present study, flavone C-glycosides, 
including vitexin (apigenin 8-C-glucoside) or isovitexin (C21H20O10; 9), and isoorientin 
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(luteolin 6-C-glucoside) (C21H20O11; 6), were detected. Compounds assigned as vitexin or 
isovitexin glycosides were also detected, including hexosides (C27H30O15; 4 and 7) and a 
pentoside (C26H28O14; 8). Other flavone C-glycosides included a compound assigned as 
isoorientin pentoside (C26H28O15; 5), assigned from the observed [M+H]
+ ion and from MS2 
and MS3 and supportive UV spectra. Isoorientin has been previously reported in A. macra 
(Ranghoo-Sanmukhiya et al., 2010).  
 
Aloin A (C21H22O9; 16) and an isomer assigned as aloin B (C21H22O9; 15) were observed as 
their [M+H]+ ions (m/z 419.1345). Additional isomers were detected with the molecular 
formulae C21H22O9, corresponding to aloin, nataloin, or their isomers (10 and 11); whilst 
compounds assigned as 6ʹ-O-malonylnataloin and isomer (C24H24O12; 18 and 19) were also 
detected. Anthraquinones and pre-anthraquinones, which are known characteristic constituents 
of the subterranean Aloes of the former genus Lomatophyllum (now included in the Aloe genus) 
have been reported (Van Wyk et al., 1995). In this present study, anthraquinones were detected, 
with qualitative differences observed. A compound (C42H42O18; 20) with m/z 835.2468, 
assigned as an aloeemodin dianthrone di-O-hexoside, was only detected in A. purpurea, A. 
lomatophylloides and A. tormentorii; whilst a compound (C30H28O11; 21) assigned as either 
microdontin A or B, or an isomer from the observed [M+H]+ ion (m/z 565.1724) was only 
detected in A. tormentorii and A. vera. Aloe-emodin dianthrone di-O-hexosides were not 
detected in A. macra or A. vera, which is in agreement with a previous conclusion that A. macra 
anthraquinone levels are lower compared to other Aloe species from Mauritius and Réunion 
Island (Ranghoo-Sanmukhiya et al., 2010). Thus, the non-prevalence of aloe-emodin 
dianthrone di-O-hexosides in A. macra might be useful to distinguish A. macra from other 
Mascarene Aloes.  
 
In summary, A. vera could be distinguished from the Mascarene Aloes by the detection of 
compounds assigned as 2ʹʹ-O-feruloylaloesin (12) and 7-O-methylaloeresin A (14), which were 
not detected in the Mascarene Aloes, thus are potentially useful chemotaxonomic markers to 
distinguish A. vera from the Mascarene Aloes.  
 
 
 
3.2. GC-MS analysis of monosaccharides 
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All species from the genus Aloe have succulent leaves but exhibit substantial variation in the 
thickness of the leaf mesophyll layer; the leaves are barely succulent in some species, whereas 
the leaf mesophyll is well developed in others (Grace et al., 2013). The present study was 
conducted to determine the Mascarene Aloes monosaccharides content. GC-MS analysis 
revealed the presence of arabinose, fucose, xylose, mannose and galactose in all the Mascarene 
Aloes and A. vera (Table 1). Arabinose was the main monosaccharide in four species, A. 
purpurea, A. tormentorii, A. lomatophylloides and Aloe spp. (WS 98002), with the highest 
concentration detected in the latter. Mannose was the primary saccharide constituent in A. 
macra (WS 980130) and A. vera, while glucose was the predominant monosaccharide in A. 
macra (WV 990110) and A. purpurea from Réunion Island. A relatively low concentration of 
fucose was detected in the Aloes, relative to the other monosaccharides detected. The 
concentration of saccharides was variable among all the species; however following a general 
trend, a lower concentration of saccharides was observed in the two A. macra samples, 
followed by A. lomatophylloides. Both A. macra and A. lomatophylloides have comparatively 
thinner leaves and the texture of the inner mesophyll ranges from firm to dry, or slightly 
mucilaginous, which may account for their restricted monosaccharide content. Previously 
Govinden-Soulange et al. (2017) differentiated the Mascarene Aloes from A. vera using NMR 
fingerprinting and PCA analysis of the sugar content of Mascarene Aloes.  
 
 
 
 
 
 
 
 
Table 1. Monosaccharides detected by GC-MS in the Mascarene Aloes and A. vera 
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Species Monosaccharide (µg/mL) 
Ara Fuc Xyl Man Gal Glu 
A. purpurea 
(Mauritius) 
204.8 15.23 98.68 192.42 34.5 48.39 
A. tormentorii 538.57 55.97 360.3 239.82 103.23 302.68 
A. lomatophylloides 106.31 9.24 53.34 40.81 35.01 94.23 
A. macra  WV 990110 29.29 1.25 9.78 35.51 
 
16.38 
 
 90.24 
A. macra WS 980130 31.28 1.89 11.63 91.56 11.56 66.19 
A. purpurea (Réunion)  100.75 13.59 98.81 215.17 238.84 377.36 
Aloe spp.  903.44 27.24 157.37 262.39 91.59 183.77 
A. vera 130.11 11.92 77.73 310.76 43.36 128.13 
Ara: arabinose, Fuc: fucose, Xyl: xylose, Man: mannose, Gal; galactose, Glu; glucose.  
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Figure 1. LC-MS chromatograms (positive mode) of the Aloe extracts. Assigned compounds (or isomer): (1) 3-O-caffeoylquinic acid; (2) aloesin; 
(3) 4-O-p-coumaroylquinic acid; (4) vitexin/isovitexin hexoside; (5) isoorientin pentoside; (6) isoorientin; (7) vitexin/isovitexin hexoside; (8) 
vitexin/isovitexin pentoside; (9) vitexin/isovitexin; (10) and (11) aloin or nataloin isomer; (12) 2ʹʹ-O-feruloylaloesin; (13) 2ʹʹ-O-trans-p-
coumaroylaloenin; (14) 7-O-methylaloeresin A; (15) aloin B; (16) aloin A; (17) aloeresin A; (18) and (19) malonylnataloin; (20) aloeemodin 
dianthrone di-O-hexoside; (21) microdontin A or B. 
 
 
15 
 
3.3. Antimicrobial activity 
The use of Aloe species to treat infections is perhaps the most popular medicinal application 
for the leaves in this genus. The antibacterial activity of the methanolic leaf extracts of the 
Mascarene Aloes and A. vera, using a micro-dilution assay, is presented in Table 2. The similar 
MIC values obtained with the Gram-negative and Gram-positive species tested in this study 
suggest that the Aloe extracts possess a broad antibacterial activity. Several studies have 
demonstrated the antibacterial activity of isolated anthraquinones from Aloes. The lack of aloe-
emodin dianthrone di-O-hexosides in the A. vera sample may account for the low antimicrobial 
activity observed, which is in agreement with the findings of Ranghoo-Sanmukhiya  et al. 
(2010).  
 
Acne is an inflammatory disease of the sebaceous glands caused by the Gram-positive 
bacterium Propionibacterium acnes. In the present study, none of the Aloe extracts tested 
displayed significant inhibitory activity against P. acnes (Table 2) at the highest test 
concentration (2 mg/mL). This indicates that while the Mascarene Aloes have been used in 
traditional medicine for skin infections, they appear to lack sufficient efficacy against P. acnes 
and are therefore unlikely to prove useful in mediating antibacterial effects as a topical 
application against acne. 
 
3.4. Anti-tyrosinase activity 
Hyper-pigmentation of the skin, caused by the over production of melanin, is a common 
problem that is prevalent in middle aged and elderly people (Mapunya et al., 2011). With the 
potential use of A. vera in cosmetic products to target hyperpigmentation, and in view of the 
chemical variation observed between A. vera and the Mascarene Aloes, the tyrosinase 
inhibitory activity of the Mascarene Aloes was evaluated.  
 
We found that, among all the Aloe extracts tested, only A. macra (WV 990110) showed 
inhibition of the enzyme, exhibiting 50% tyrosinase inhibition at 0.95 mg/mL, as compared to 
the positive control kojic acid, 0.003 mg/mL (Table 2). A number of flavonoids such as 
quercetin, luteolin, apigenin, taxifolin have also been associated with tyrosinase inhibition (Xie 
et al., 2003; An et al., 2008). Chromones and flavonoids may therefore have contributed to the 
anti-tyrosinase activity of the A. macra extract in this study, and our results suggest that this 
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species may be explored further for its ability to inhibit melanin production and potential for 
its sustainable cultivation for use in cosmetics. 
 
Table 2: Antibacterial and anti-tyrosinase activity of crude extracts of A. vera and Mascarene 
Aloe species 
a: streptomycin; b:tetracycline; c: Kojic acid; *weak activity; -: no activity; ** highest concentration tested: 1 
mg/mL; *** highest concentration tested: 2mg/mL. BC: Bacillus cereus; SA: Staphylococcus aureus; P. ac: 
Propionibacterium acnes; EC: Escherichia coli; PA: Pseudomonas aeruginosa; KP: Klebsiella pneumoniae 
 
3.5. Wound healing properties 
The wound healing activity of A. vera has been studied extensively. To investigate the 
influence of the Aloe extracts on fibroblast migration and proliferation into the wounded 
monolayer, a scratch assay was employed with HaCaT cells. All extracts were tested at a 
concentration of 0.1 mg/mL and stimulation rate was expressed as a percentage of the closed 
area. The closed area with extracts of A. purpurea (Mauritius) was 74.1 %, and for A. vera, 
64.2 % (Figure 2) compared to the controls, with 64.9 % and 56.4% closed area respectively. 
These results indicate that A. purpurea (Mauritius) and A. vera have modest activity to reduce 
the damaged area after physical injury. To date, the relationship between various Aloe 
components and their wound healing effects has not been sufficiently elucidated. 
Polysaccharides such as acemannan from Aloe species have been associated with wound 
healing effects (Barbul, 1990; Jia et al., 2008; Chantarawaratit et al., 2013).  
Test samples 
Antibacterial (MIC) 
 (mg/mL) 
Tyrosinase 
(mg/mL) 
BC SA P. ac** EC PA KP IC50±SD*** 
A. purpurea (Mauritius) 12.5 6.25 ¯ 3.125 ¯ ¯ ¯ 
A. tormentorii 6.25 3.13 ¯ 25* ¯ ¯ ¯ 
A. lomatophylloides 12.5 6.25 ¯ 1.56 ¯ ¯ ¯ 
A. macra  (WV 990110) 12.5 3.13 ¯ 3.13 6.25 ¯ 0.95±16.1 
A. purpurea (Réunion) 6.25 1.56 ¯ 3.13 3.13 3.13 ¯ 
A. vera 12.5 25* ¯ 25* ¯ ¯ ¯ 
Positive  control   3.13a 0.78a 0.0008b 0.01a 0.78a 0.16a 0.003±0.05c 
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Anthraquinone and derivatives are also known to promote wound healing via multiple 
mechanistic effects, such as anti-inflammatory and antioxidant activities. However, aloe-
emodin exhibits contradictory activities on cell growth and proliferation and it has been 
reported to produce a 2.5-fold increase in DNA synthesis of primary hepatocytes with a 
corresponding increase in cell growth (Wölfle et al., 1990). In contrast, aloe-emodin results in 
apoptosis-inducing effects in human squamous cell carcinoma (Lee, 2001; Lee et al., 2001). 
Such contradictory activities of aloe-emodin may be due to its antioxidant/prooxidant behavior, 
differences in concentration and the conditions of testing. Aloesin and aloin also appear to  
accelerate skin wound healing both in vitro and in vivo (Wahedi et al., 2017; Li et al., 2017), 
and may therefore have contributed to the moderate wound healing activity observed with A. 
purpurea (Mauritius) and A. vera in this present study, although other constituents potentially 
responsible for the observed effects require further investigation.   
 
 
Figure 2. Effect of Mascarene Aloe extracts on the migratory and proliferative activity of 
HaCaT cells in the scratch assay after 24 h of incubation. Data are expressed as a percentage 
of closed area relative to the control. * p < 0.05 compared to control. APM: A. purpurea 
(Mauritius); AT: A. tormentorii; AL: A. lomatophylloides; AM: A. macra; APR: A. purpurea 
(Réunion); AV: A. vera 
 
3.6. Cytotoxic activity 
Cytotoxicity is an important factor to consider when evaluating the therapeutic potential of 
medicinal plants. The cytotoxic activity of the Mascarene Aloes and A. vera was analysed in 
vitro against human promyelocytic leukaemia cells (HL60) cells and MRC 5 fibroblast cells. 
The results showed that only A. purpurea (Réunion; 0.1 mg/mL) elicited a modest toxic effect 
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against HL60 cells, with toxicity observed at 8.2% (Figure 3). None of the other Aloe extracts 
produced a toxic effect upon MRC 5 fibroblast cells at a concentration of 0.1 mg/mL. A. 
purpurea (Réunion), followed by A. purpurea (Mauritius) and A. vera, displayed an apparent 
proliferative activity upon the MRC 5 fibroblast cells (Figure 3). The presence of 
anthraquinone derivatives such as aloin A and B, aloesin and aloe-emodin dianthrone di-
hexosides in the investigated Aloes may have contributed to the toxicity observed with the 
HL60 cells. Indeed, the toxic activity of aloe-emodin upon HL60 cells has previously been 
reported, concluding that it shows potential as an anti-cancer lead (Chen et al., 2002).  
The MRC-5 human fibroblast cell line is a well-characterised cell culture system to investigate 
ageing and senescence, and it is known that ROS play a critical role during the course of 
senescence (Nelson et al., 2012). As some of the Mascarene Aloes have demonstrated 
antioxidant capability (Govinden-Soulange et al., 2017), and since these were not associated 
with cytotoxcity or negative effects on the process of ageing and senescence in the MRC-5 cell 
line, it may be hypothesised that extracts from the Mascarene Aloes have potential for use in 
topical cosmetic formulations. In addition, the tyrosinase inhibitory activity seen with A. macra 
may offer an additional advantage for application in cosmetic products. 
 
 
 
Figure 3. Treatment of HL60 cells and MRC5 Fibroblast cells with Aloe extracts for 24 h. 
APM: A. purpurea (Mauritius); AT: A. tormentorii; AL: A. lomatophylloides; AM: A. macra; 
APR: A. purpurea (Réunion) and AV: A. vera. * p < 0.05 compared to control 
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4. Conclusions  
Evaluation of the literature provides support for the therapeutic value of the genus Aloe, 
particularly in medicinal applications for25% of its species (Grace et al., 2009). The present 
study provides fresh evidence for the potential value of the Mascarene Aloes, to validate their 
traditional uses, whilst also suggesting new uses for both medicinal and cosmetic applications. 
Some of the species investigated have been shown to have a broader spectrum of antimicrobial 
activity, particularly A. purpurea from Réunion; whereas others show potential for use in 
cosmetics, considering their previously reported antioxidant capacity, reported to be superior 
to that of A. vera (Govinden-Soulange et al., 2017) and for A. macra (WV 990110), which 
possesses tyrosinase inhibitory activity. A. purpurea from Mauritius has been shown to have 
wound healing activity in vitro. Phytochemical studies concluded that species from Réunion 
Island contain higher concentrations of saccharides compared to other Mascarene Aloes, while 
more than twenty other compounds were characterised in the Aloe extracts.  
We therefore conclude that the Mascarene Aloes are a potential source of new medicinal or 
cosmetic natural products, whilst further research on these species is justified to unveil their 
chemical diversity, which is not only relevant for their therapeutic potential, but may also to 
encourage their sustainable cultivation. The trade of many Aloe species is restricted under the 
Convention of International Trade in Endangered Species of Wild Fauna and Flora (CITES, 
2015), therefore the results from this study will further advocate the conservation of these 
Mascarene Aloes, which has been a key focus in previous work (Lobine et al., 2015) and which 
remains essential for the preservation of the floral biodiversity of these Islands. 
Acknowledgements 
The authors acknowledge Mrs Rebecca Manning, Department of Biosciences, Durham 
University for assistance with the Scratch assay; Dr Nicholas Hole, Durham University for 
providing the HL60 cells; and Dr Geoffrey C. Kite, Royal Botanic Gardens, Kew, for 
acquisition of LC-MS data. 
 
 
 
 
Funding 
 
 
20 
 
This work was supported by the Commonwealth Scholarship Commission; the Durham 
Biophysical Sciences Institute 1+1 Fellowship at Durham University and Tertiary Education 
Commission (Mauritius). 
 
 
References 
1. Abuhamdah, S., Abhuhamdah, R., Howes, M-J, R, Al-Olimat, S., Ennaceur, A. and 
Chazot, P.L. (2015). Pharmacological and neuroprotective profile of an essential oil 
derived from leaves of Aloysia citrodora Palau. J. of Pharm. Pharmacol. 67(9), 1306-
15. 
2. An, S. M., Kim, H. J., Kim, J.-E and Boo, Y. C. (2008). Flavonoids, taxifolin and 
luteolin attenuate cellular melanogenesis despite increasing  tyrosinase protein levels. 
Phytother. Res. 22, 1200–1207. doi:10.1002/ptr.2435 
3. Barbul, A. (1990). Immune aspects of wound repair. Clinics in Plast. Surg. 17, 433–
442. 
4. Bisrat, D., Dagne, E., Wyk, B.E.V and Viljoen, A.. (2000). Chromones and anthrones 
from Aloe marlothii and Aloe rupestris. Phytochem. 55(8), 949–952. 
5. Bosser, J., Cadet, Th., Gueho, J., Julier, HR. and Marais, W. (1976). Flore des 
Mascareignes: La Reunion, Maurice, Rodrigues. Mauritius Sugar Industry Research 
Institute: Port Louis, Mauritius, L’Office de la Recherche Scientifique et Technique 
Outremer: Paris and the Royal Botanic Gardens: Kew. [in French] 
6. British Pharmacopoeia Commission. (2017). British Pharmacopoeia. Vol. IV. The 
Stationery Office, London 
7. Chantarawaratit, P., Sangvanich, P., Banlunara, W., Soontornvipart, K., 
Thunyakitpisal, P.(2013). Acemannan sponges stimulate alveolar bone, cementum and 
periodontal ligament regeneration in a canine class II furcation defect model. J 
Periodontal Res.49, 164e178. 
8. Chen, Y.C., Shen, S.C., Lee, W.R., Hsu, F-L., Lin, H.Y., Ko, C.H., and Tseng, S.W. 
(2002). Emodin induces apoptosis in human promyeloleukemic HL-60 cells 
accompanied by activation of caspase 3 cascade but independent of reactive oxygen 
species production. Biochem. pharmacol. 64(12), 1713-1724. 
 
 
21 
 
9. Chinchilla, N., Carrera, C., Durán, A.G., Macías, M., Torres, A. and Macías, F.A. 
(2013). Aloe barbadensis: how a miraculous plant becomes reality. Phytochem. Rev. 
12(4), 581-602 
10. CITES [online] 2015; https://cites.org/sites/default/files/eng/app/2015/E-Appendices-
2015-02-05.pdf (accessed 20 December 2015) 
11. Cock, I .E (2015). The Genus Aloe: Phytochemistry and therapeutic uses including 
treatment for gastrointestinal conditions and chronic inflammation.. Novel Natural 
Products: Therapeutic Effects in Pain, Arthritis and Gastro-intestinal Diseases pp 179-
235 (Eds K. D. Rainsford, M. C. Powanda and  M. W. Whitehouse)  Springer Basel 
12. Dagne, E., Bisrat, D., Viljoen, A. and Van Wyk, B.E. (2000). Chemistry of Aloe species. 
Curr. Org. Chem. 4(10), 1055-1078. 
13. Eloff, J.N. (1998). A sensitive and quick microplate method to determine the minimal 
inhibitory concentration of plant extracts for bacteria. Planta med. 64(8), 711-713 
14. Gebäck, T., Schulz, M.M.P., Koumoutsakos, P. & Detmar, M. (2009). TScratch: A 
novel and simple software tool for automated analysis of monolayer wound healing 
assays. BioTechniques. 46(4), 265-74 
15. Govinden-Soulange J., Lobine D., Frederich M., Kodja H., Coetzee M.P.A., Ranghoo-
Sanmukhiya V.M. (2017). Metabolomic and molecular signatures of Mascarene Aloes 
using a multidisciplinary approach. S. Afr. J. of Bot. 108, 137–143 
16. Govinden-Soulange, J. (2014) Healing Aloes from the Mascarenes Islands. In: Novel 
Plant Bioresources: Applications in Food, Medicine and Cosmetics pp 205-214 (Ed A. 
Gurib-Fakim), John Wiley & Sons, Ltd, Chichester, UK 
17. Grace, O.M. (2011). Current perspectives on the economic botany of the genus Aloe L. 
(Xanthorrhoeaceae). S. Afr. J. of Bot. 77(4), 980-987. 
18. Grace, O.M., Dzajic, A., Jäger, A.K., Nyberg, N.T.,Onder, A. and Ronsted, N. (2013). 
Monosaccharide analysis of succulent leaf tissue in Aloe. Phytochem. 93, 79-87 
19. Grace, O.M., Simmonds, M.S.J, Smith, G.F. and van Wyk, A.E. (2008). Theraupeutic 
uses of Aloe L. (Asphodelaceae) in southern Africa. J. Ethnopharmacol. 119, 604-614. 
20. Grace, O.M., Simmonds, M.S.J., Smith, G.F. and van Wyk, A.E. (2009). Documented 
utility and biocultural value of Aloe L. (Asphodelaceae): A review. Econ. Bot. 63(2), 
167-178. 
21. Gurib-Fakim A.  2003. An Illustrated Guide to the Flora of Mauritius and the Indian 
Ocean Islands. Caractère Ltée: Baie du Tombeau, Mauritius, 2003. 
 
 
22 
 
22. Jia, Y., Zhao, G. and Jia, J. (2008). Preliminary evaluation: the effects of Aloe ferox 
Miller and Aloe arborescens Miller on wound healing. J. Ethnopharmacol. 120(2), 181-
189. 
23. Lee, H.Z. (2001). Protein kinase C involvement in aloe-emodin and emodin-induced 
apoptosis in lung carcinoma cell. Br J Pharmacol 134, 1093-1103. 
24. Lee, H.Z., Hsu, S.L., Liu, M.C. and Wu, CH. (2001). Effects and mechanisms of aloe-
emodin on cell death in human lung squamous cell carcinoma. Eur J Pharmacol 431, 
287-295. 
25. Li, L.J., Gao, S-Q., Peng, L-H., Wang, X-R., Zhang, Y., Hu, Z-J., and Gao, J-Q. (2017) 
Evaluation of efficacy of aloin in treating acute trauma in-vitro and in-vivo. Biomed. 
Pharmacother. 88, 1211-1219 
26. Lobine, D., .Govinden-Soulange, J., Ranghoo Sanmukhiya. M. and Lavergne, C. 
(2015). A tissue culture strategy towards the rescue of endangered Mascarene Aloes. 
ARPN J. Agric. and Biol. Sci. 10(1), 28-38  
27. Lobine, D., Howes, M-J.R., Cummins, I., Govinden-Soulange, J., Ranghoo-
Sanmukhiya,M., Lindsey, K. and Chazot, P.L. (2017). Bioprospecting endemic 
Mascarene Aloes for potential neuroprotectants. Phytother Res (In press) doi: 
10.1002/ptr.5941 
28. Mapunya, M.B., Hussein, A.A., Rodriguez, B. and Lall, N. (2011). Tyrosinase activity 
of Greyia flanaganii (Bolus) constituents. Phytomed. 18, 1006-1012. 
29. Momtaz S, Lall N, Basson A (2008) Inhibitory activities of mushroom tyrosine and 
DOPA oxidation by plant extracts. S. Afr. J. of Bot. 74: 577–582. 
30. Nelson, G., Wordsworth, J., Wang C., Jurk, D., Lawless, C., Martin-Ruiz, C. and Von 
Zglinicki, T. (2012). A senescent cell bystander effect: senescence-induced senescence. 
Aging Cell 11(2), 345-349 
31. Pailler T, Picot F, Lavergne C, Strasberg D. 2000. [Statut démographique et biologie 
de la reproduction d’une espèce endémique menacée de l’île de La Réunion: 
Lomatophyllum macrum (Haw.) Salm-Dyck (Liliacées).] Rev Écol (Terre et Vie) 55: 
201-214 [in French] 
32. Pilarski, R., Poczekai-Kostrzewska, M., Ciesiolka, D., Szyfter, K. and Gulewicz, K. 
(2007). Antiproliferative activity of various Uncaria tomentosa preparations on HL-60 
promyelocytic leukemia cells. Pharmacol. Rep. 59(50), 565-72 
33. Ranghoo-Sanmukhiya, M., Govinden-Soulange, J., Lavergne, C., Khoyratty, S., Da 
Silva, D., Frederich, M. and Kodja, H. (2010). Molecular biology, phytochemistry and 
 
 
23 
 
bioactivity of three endemic Aloe species from Mauritius and Réunion islands. 
Phytochem. Anal. 21(6), 566-574. 
34. Schymanski, E.L., Jeon, J., Gulde, R., Fenner, K., Ruff, M., Singer, H.P, Hollender, J. 
(2014) Identifying small molecules via high resolution mass spectrometry: 
communicating confidence. Environ. Sci. Technol. 48, 2097-20 
35. Sharma, R., Kishore, N., Hussein, A., Lall, N. (2014). The potential of Leucosidea 
sericea against Propionibacterium acnes. Phytochem. Lett. 7,124–129. 
36. Van Wyk, B.E., Yenesew, A. and Dagne, E. (1995). Chemotaxonomic survey of 
anthraquinones and preanthraquinones in roots of Aloe species. Biochem. Syst. Ecol. 
23(3), 267-275. 
37. Viljoen, A.M. and Van Wyk, B.E. (2000). The chemotaxanomic significance of the 
phenyl pyrone aloenin in the genus Aloe. Biochem. Syst. Ecol. 28, 1009-1017 
38. Viljoen, A.M., Van Wyk, B.E and Heerden, F.R. (1998). Distribution and 
 chemotaxonomic significance of flavonoids in Aloe (Asphodelaceae). Plant Syst. 
Evol. 211, 31-42. 
39. Wahedi, H.M., Jeong, M., Chae, J.K., Do, S.G, Yoon, H. Kim, S.Y. (2017) Aloesin 
from Aloe vera accelerates skin wound healing by modulating MAPK/Rho and Smad 
signaling pathways in-vitro and in-vivo. Phytomed. 28, 19-26 
40. Wolfle, D., Schmutte, C., Westendorf, J and Hans, Marquardt. (1990). 
Hydroxyanthraquinones as tumor promoters: Enhancement of malignant  
transformation of C3H mouse fibroblasts and growth stimulation of primary rat 
hepatocytes. Cancer Res, 50. 6540-6544 
41. Xie, L.P., Chen Q.X., Huang, H., Wang, H.Z. and Zhang, R.Q. (2003).Inhibitory effects 
of some flavonoids on the activity of mushroom tyrosinase. Biochem. (Mosc), 64(4), 
487-91.  
